Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection

To define the impact of coinfection with hepatitis B virus (HBV) or hepatitis C virus (HCV) on viroimmunological response to raltegravir-based salvage regimens that also include new HIV inhibitors such as maraviroc, darunavir and etravirine. We used data from a national observational study of patien...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of antimicrobial chemotherapy 2013-01, Vol.68 (1), p.193-199
Hauptverfasser:	Weimer, Liliana Elena, Fragola, Vincenzo, Floridia, Marco, Guaraldi, Giovanni, Ladisa, Nicoletta, Francisci, Daniela, Bellagamba, Rita, Degli Antoni, Anna, Parruti, Giustino, Giacometti, Andrea, Manconi, Paolo Emilio, Vivarelli, Angela, D'Ettorre, Gabriella, Mura, Maria Stella, Cicalini, Stefania, Preziosi, Roberta, Sighinolfi, Laura, Verucchi, Gabriella, Libertone, Raffaella, Tavio, Marcello, Sarmati, Loredana, Bucciardini, Raffaella
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antiretroviral drugs CD4 antigen Cohort Studies Coinfection - drug therapy Coinfection - epidemiology copy number Data processing Drug abuse Drugs Female Follow-Up Studies Health risk assessment Hepacivirus - drug effects Hepatitis Hepatitis B Hepatitis B - drug therapy Hepatitis B - epidemiology Hepatitis B virus Hepatitis B virus - drug effects Hepatitis C Hepatitis C - drug therapy Hepatitis C - epidemiology Hepatitis C virus HIV HIV Infections - drug therapy HIV Infections - epidemiology Human immunodeficiency virus Humans Immunology Infection Intravenous administration Liver Male Middle Aged Original Research Salvage Therapy - methods Toxicity Treatment Outcome Virology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!